Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Reexamination Certificate
2006-08-29
2006-08-29
Webman, Edward J. (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
C424S448000
Reexamination Certificate
active
07097853
ABSTRACT:
A transdermal drug delivery device involving a macromonomer-containing acrylate or methacrylate copolymer, a softener, and a drug. Also a pressure sensitive skin adhesive involving a macromonomer containing acrylate or methacrylate copolymer and a softener.
REFERENCES:
patent: RE24906 (1960-12-01), Ulrich
patent: 3786116 (1974-01-01), Milkovich et al.
patent: 3832423 (1974-08-01), Milkovich et al.
patent: 3842057 (1974-10-01), Milkovich et al.
patent: 3842058 (1974-10-01), Milkovich et al.
patent: 3842059 (1974-10-01), Milkovich et al.
patent: 3842146 (1974-10-01), Milkovich et al.
patent: 3862077 (1975-01-01), Schulz et al.
patent: 3862098 (1975-01-01), Milkovich et al.
patent: 3862101 (1975-01-01), Milkovich et al.
patent: 3862102 (1975-01-01), Milkovich et al.
patent: 3879494 (1975-04-01), Milkovich et al.
patent: 3928255 (1975-12-01), Milkovich et al.
patent: 3989768 (1976-11-01), Milkovich et al.
patent: 4085168 (1978-04-01), Milkovich et al.
patent: 4260659 (1981-04-01), Gobran
patent: 4304591 (1981-12-01), Mueller et al.
patent: 4374883 (1983-02-01), Winslow
patent: 4551388 (1985-11-01), Schlademan
patent: 4554324 (1985-11-01), Husman et al.
patent: 4656213 (1987-04-01), Schlademan
patent: 4693776 (1987-09-01), Krampe et al.
patent: 4732808 (1988-03-01), Krampe
patent: 4737559 (1988-04-01), Kellen et al.
patent: 4751087 (1988-06-01), Wick
patent: 4818540 (1989-04-01), Chien et al.
patent: 4847137 (1989-07-01), Kellen et al.
patent: 4851278 (1989-07-01), Enanoza
patent: 4871812 (1989-10-01), Locast et al.
patent: 4883669 (1989-11-01), Chien et al.
patent: 4906169 (1990-03-01), Chien et al.
patent: 4946742 (1990-08-01), Landin
patent: 4973468 (1990-11-01), Chiang et al.
patent: 4994267 (1991-02-01), Sablotsky
patent: 4994322 (1991-02-01), Delgado et al.
patent: 5006582 (1991-04-01), Manicinelli
patent: 5023084 (1991-06-01), Chien et al.
patent: 5032637 (1991-07-01), Therriault et al.
patent: 5053227 (1991-10-01), Chiang et al.
patent: 5059426 (1991-10-01), Chiang et al.
patent: 5143972 (1992-09-01), Groves
patent: 5145682 (1992-09-01), Chien et al.
patent: 5151271 (1992-09-01), Otsuka et al.
patent: 5175052 (1992-12-01), Tokuda et al.
patent: 5176916 (1993-01-01), Yamanaka et al.
patent: 5200190 (1993-04-01), Azuma et al.
patent: 5225473 (1993-07-01), Duan
patent: 5229195 (1993-07-01), Maruoka et al.
patent: 5244677 (1993-09-01), Kreckel
patent: 5252395 (1993-10-01), Maruoka et al.
patent: 5262165 (1993-11-01), Govil et al.
patent: 5296230 (1994-03-01), Chien et al.
patent: 5298258 (1994-03-01), Akemi et al.
patent: 5302629 (1994-04-01), Berejka
patent: 5306503 (1994-04-01), Müller et al.
patent: 5352516 (1994-10-01), Therriault et al.
patent: 5368860 (1994-11-01), Sunami et al.
patent: 5372819 (1994-12-01), Godbey et al.
patent: 5389376 (1995-02-01), Duan
patent: 5395907 (1995-03-01), Zajaczkowski
patent: 5508367 (1996-04-01), Zajackowski
patent: 5573778 (1996-11-01), Therriault et al.
patent: 5614210 (1997-03-01), Braun
patent: 5660178 (1997-08-01), Kantner et al.
patent: 0183386 (1986-06-01), None
patent: 0353677 (1990-02-01), None
patent: 399432 (1990-11-01), None
patent: 455458 (1991-11-01), None
patent: 0491169 (1992-06-01), None
patent: 0501124 (1992-09-01), None
patent: 554106 (1993-08-01), None
patent: 732100 (1996-09-01), None
patent: 57-125753 (1982-08-01), None
patent: 58-176208 (1983-10-01), None
patent: 60-228413 (1985-11-01), None
patent: 01-213379 (1989-08-01), None
patent: 93/06184 (1993-04-01), None
patent: 94/13750 (1994-06-01), None
Chemical Abstracts, vol. 96, No. 20 (May 17, 1982); Abstract No. 168739 (Japanese Patent No. 57-011916).
Textbook of Polymer Science, Wiley Interscience, pp. 84 and 85, 1971.
Pfister et al., “Developing Drug-Compatible Adhesives for Transdermal Drug Delivery Devices.”Pharmaceutical Technology, pp. 42-58, Jan. 1992.
Pfister et al., “Permeation Enhancers Compatible with Transdermal Drug Delivery Systems: Part II: System Design Considerations,”Pharmaceutical Technology, pp. 54-60, Oct. 1990.
Schulz et al., “Functionality Terminal Polymers via Anionic Methods,”Anionic Polymerization, American Chemical Society, Chapter 27, pp. 427-440, 1981.
“Compliance Test Method,” pp. 15-16 from Appln. No. 08/968,519 (TX 1008).
Letters between Herbert H. Mintz and James W. Helliwege, Jan.-Feb. 1999 (TX 1009-1014).
Declaration of Jane Workinger in Support of Therriault Preliminary Motions 2, 3, and 5, Mar. 8, 1999 (TX 1015).
Declaration of Michael J. Zajaczkowski to Correct Inventorship, Mar. 4, 1999 (TX 1016).
Assent of Adhesive Research, Inc. to Correct Inventorship, Mar. 11, 1999 (TX 1017).
Declaration of Donald J. Therriault to Correct Inventorship, Mar. 2, 1999 (TX 1018).
Declaration of Kenneth W. Rodgers to Correct Inventorship, Mar. 9, 1999 (TX 1019).
Petition to Correct Inventorship Pursuant to 37 CFR 1.324, Mar. 9, 1999 (TX 1020).
Substitute Declaration for Patent Application Mar. 1999 (TX 1021).
Adhesive Bonding, L. Lee, ed., Secs. 2.2, 3.1-3.3, and 4.1, pp. 36-38, 1991 (TX 1022).
Declaration of Michael J. Zajaczkowski in Support of Therriault Preliminary Motion 4, Mar. 9, 1999 (TX 1023).
Pages 214-217 from Mark T. Keller Notebook, Mar. 28, 1991 (TX 1024).
Declaration of James W. Hellwege in Support of Therriault Miscellaneous Motion 8, Apr. 14, 1999 (TX 1026).
Second Declaration of Michae J. Zajaczkowski in Support of Therriault Second Preliminary Motion 4, Apr. 23, 1999 (TX 1027).
Office Action in Therriault Appln. No. 08/405,872, Sep. 21, 1995 (GX 2001).
Request for Reconsideration in Therriault Appln. No. 08/405,872, Mar. 21, 1996 (GX 2002).
File History of EP Application No. 96301769.4 (EP 732 100), filed Mar. 15, 1996.
Notice Declaring Interference No. 104,263, Nov. 9, 1998.
Therriault Preliminary Motion 1, Mar. 9, 1999.
Therriault Preliminary Motion 2, Mar. 9, 1999.
Therriault Preliminary Motion 3, Mar. 9, 1999.
Therriault Preliminary Motion 4, Mar. 9, 1999.
Therriault Miscellaneous Motion 5, Mar. 9, 1999.
Therriault Motion to Correct Inventorship 6, Mar. 9, 1999.
Supplement to Therriault Motion to Correct Inventorship 6, Mar. 15, 1999.
Garbe Opposition 5, Mar. 26, 1999.
Garbe Motion 1, Mar. 26, 1999.
Proposed Amendment Related to Garbe Motion 1, Mar. 26, 1999.
Therriault Reply 5, Apr. 2, 1999.
Therriault Preliminary Motion 7, Apr. 14, 1969.
Therriault Miscellaneous Motion 8, Apr. 14, 1999.
Order (Paper No. 35), Apr. 6, 1999.
Therriault Consent to Grant of Garbe Preliminary Motion 1, Apr. 19, 1999.
Notice of Withdrawal of Therriault Preliminary Motions 2 and 3 and Miscellaneous Motion 5, Apr. 19, 1999.
Order (Paper No. 40), Apr. 19, 1999.
Order (Paper No. 44), Apr. 21, 1999.
Therriault Second Preliminary Motion 4, Apr. 23, 1999.
Order (Paper No. 47), Apr. 27, 1999.
Withdrawal by Party Therriault of Second Preliminary Motion 4, Jun. 18, 1999.
Stipulation Regarding Therriault Preliminary Motion 6, Jun. 24, 1999.
Garbe Motion No. 2, Jul. 6, 1999.
Proposed Amendment Related to Garbe Motion No. 2, 1999.
Garbe Opposition to Therriault Motion No. 7, Aug. 9, 1999.
Therriault Opposition 2, Aug. 9, 1999.
Therriault Preliminary Motion 9, Aug. 9, 1999.
Therriault Miscellaneous Motion 10, Aug. 9, 1999.
Decision on Motion (Paper No. 60), Aug. 13, 1999.
Therriault Consent to Garbe Motion 2, Aug. 30, 1999.
Garbe Supplemental Opposition to Therriault Motion No. 7, Sep. 10, 1999.
Therriault Reply to Garbe Opposition and Supplemental Opposition to Therriault Motion 7, Sep. 24, 1999.
Order (Paper No. 72), Oct. 21, 1999.
Garbe's List of Pending Claims 1-34, Oct. 26, 1999.
Memorandum Opinion and Order (Paper No. 73), Oct. 27, 1999.
Garbe's Notice Pursuant to 37 C.F.R § 1.632 of Intent to Argue Abandonement, Suppression or Concealment, Apr. 18, 2000.
Garbe's Statement of Issues Under 37 C.F.R. 1.640(b), Jul. 25, 2000.
[Therriault's]Issues to Be Considered Under 37 C.F.R. 1.640(b), Jul. 25, 2000.
Junior Party Principal Brief on Issue Priority, Sep. 15, 2000.
Senior Party Garbe's Opening Brief, Oct. 25, 2000.
Junior Party Brief in Opposition to Senior Party Principal Brief, Nov. 8, 200
Duan Daniel C.
Garbe James E.
Keister Jamieson C.
Ko Chan U.
Moore Cheryl L.
3M Innovative Properties Company
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Webman Edward J.
LandOfFree
Matrix for transdermal drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Matrix for transdermal drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix for transdermal drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3653744